These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2037103)

  • 21. Polycystic ovarian disease: animal models.
    Mahajan DK
    Endocrinol Metab Clin North Am; 1988 Dec; 17(4):705-32. PubMed ID: 2973982
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The abnormal response of polycystic ovarian disease patients to exogenous pulsatile gonadotropin-releasing hormone: characterization and management.
    Filicori M; Flamigni C; Campaniello E; Valdiserri A; Ferrari P; Meriggiola MC; Michelacci L; Pareschi A
    J Clin Endocrinol Metab; 1989 Oct; 69(4):825-31. PubMed ID: 2506216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Endocrinological environment in polycystic ovarian disease (PCOD)].
    Fujimoto S; Tanaka T
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Sep; 40(9):1465-70. PubMed ID: 3049852
    [No Abstract]   [Full Text] [Related]  

  • 24. Endocrinological and clinical analysis of hyperprolactinemic patients with and without ultrasonically diagnosed polycystic ovarian changes.
    Işik AZ; Gülekli B; Zorlu CG; Ergin T; Gökmen O
    Gynecol Obstet Invest; 1997; 43(3):183-5. PubMed ID: 9127132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overnight secretion pattern of growth hormone, sex hormone binding globulin, insulin-like growth factor-1 and its binding protein in obese and non-obese women with polycystic ovarian disease.
    Insler V; Barash A; Shoham Z; Koistinen R; Seppala M; Hen M; Lunenfeld B; Zadik Z
    Isr J Med Sci; 1994 Jan; 30(1):42-7. PubMed ID: 7511134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of a positive family history of type 2 diabetes in women with polycystic ovarian disease.
    Fox R
    Gynecol Endocrinol; 1999 Dec; 13(6):390-3. PubMed ID: 10685332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polycystic ovarian disease: sonographic spectrum.
    Hann LE; Hall DA; McArdle CR; Seibel M
    Radiology; 1984 Feb; 150(2):531-4. PubMed ID: 6691114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changing pituitary reactivity to follicle-stimulating hormone and luteinizing hormone-releasing hormone after induced ovulatory cycles and after anovulation in patients with polycystic ovarian disease.
    Blankstein J; Rabinovici J; Goldenberg M; Shaley J; Mehta A; Serr DM; Mashiach S
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1164-7. PubMed ID: 3119650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of obesity on the clinical and hormonal characteristics of the polycystic ovary syndrome.
    Singh KB; Mahajan DK; Wortsman J
    J Reprod Med; 1994 Oct; 39(10):805-8. PubMed ID: 7837128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of adrenal versus ovarian androgen ratio on signs and symptoms of polycystic ovarian syndrome.
    Köşüş N; Köşüş A; Kamalak Z; Hızlı D; Turhan NÖ
    Gynecol Endocrinol; 2012 Aug; 28(8):611-4. PubMed ID: 22296561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Classification of normogonadotropic infertility: polycystic ovaries diagnosed by ultrasound versus endocrine characteristics of polycystic ovary syndrome.
    van Santbrink EJ; Hop WC; Fauser BC
    Fertil Steril; 1997 Mar; 67(3):452-8. PubMed ID: 9091329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hirsutism and oligomenorrhea are appropriate screening criteria for polycystic ovary syndrome in adolescents.
    Villarroel C; López P; Merino PM; Iñiguez G; Sir-Petermann T; Codner E
    Gynecol Endocrinol; 2015; 31(8):625-9. PubMed ID: 26190534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease.
    Fauser BC; Pache TD; Lamberts SW; Hop WC; de Jong FH; Dahl KD
    J Clin Endocrinol Metab; 1991 Oct; 73(4):811-7. PubMed ID: 1909705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
    Hassa H; Tanir HM; Yildiz Z
    Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endocrine features of polycystic ovary syndrome in a random population sample of 14-16 year old adolescents.
    van Hooff MH; Voorhorst FJ; Kaptein MB; Hirasing RA; Koppenaal C; Schoemaker J
    Hum Reprod; 1999 Sep; 14(9):2223-9. PubMed ID: 10469684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adolescent menstrual irregularity.
    Mansfield MJ; Emans SJ
    J Reprod Med; 1984 Jun; 29(6):399-410. PubMed ID: 6379175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease.
    Burghen GA; Givens JR; Kitabchi AE
    J Clin Endocrinol Metab; 1980 Jan; 50(1):113-6. PubMed ID: 7350174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Has oligomenorrhea a pathological meaning? The importance of this symptom in internal medicine].
    Devoto E; Aravena L; Gaete X
    Rev Med Chil; 1998 Aug; 126(8):943-51. PubMed ID: 9830746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polycystic ovarian disease.
    Raj SG; Talbert LM
    Obstet Gynecol Annu; 1984; 13():261-73. PubMed ID: 6232474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endocrinological environment of polycystic ovarian disease.
    Tanaka T; Fujimoto S
    Horm Res; 1990; 33 Suppl 2():5-9. PubMed ID: 2128882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.